CUSIP 171757107StockQ4 2025
26 filings · latest Feb 14, 2024
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Crestwood Advisors Group, LLC | 7.7K | $1.70M |
| 2 | Eversource Wealth Advisors, LLC | 314 | $69.4K |
| 3 | Rothschild Investment LLC | 26 | $5.7K |
| 4 | Farther Finance Advisors, LLC | 19 | $4.2K |
| 5 | Thoroughbred Financial Services, LLC | 5.6K | $1.2K |
| 6 | Bare Financial Services, Inc | 2 | $442 |
| 4 | Feb 14, 2023 | Nantahala Capital Management, LLC | 13G/A | 6.1% | 4.37M | SEC |
| 5 | Feb 14, 2023 | Point72 Asset Management, L.P. | 13G/A | 5.4% | 3.87M | SEC |
| 6 | Feb 15, 2022 | Lytton Laurence W | 13G/A | 2.5% | 1.71M | SEC |
| 7 | Feb 14, 2022 | Omega Fund V, L.P. | 13G/A | 1.8% | 1.25M | SEC |
| 8 | Feb 14, 2022 | Nantahala Capital Management, LLC | 13G | 7.9% | 5.27M | SEC |
| 9 | Feb 14, 2022 | Point72 Asset Management, L.P. | 13G/A | 6.3% | 4.20M | SEC |
| 10 | Feb 11, 2022 | Bb Biotech AG | 13G/A | — | — | SEC |
See the full Schedule 13D/13G history for Cidara Therapeutics Inc Com New.
Unlock full history